ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ)
$8.1 -0.08 (-0.978%)
Analysed ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) News Sources
ACHV: CEO Enlists New Commercialization Team
13-05-2026
yahoo.com
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
19-05-2026
yahoo.com
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
02-06-2026
yahoo.com
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
22-06-2026
yahoo.com
Achieve Life Sciences Joins Russell 2000® Index
29-06-2026
yahoo.com
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting
10-07-2026
marketbeat.com
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
31-07-2026
yahoo.com
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
11-08-2026
yahoo.com
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.
12-08-2026
barchart.com
ACHV: Looking Ahead to Resubmission
18-08-2026
yahoo.com
What is the current price of ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ)?
The current price of ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) is $8.1.
ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) absolute price change since previous trading day?
The absolute price change of ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) since the previous trading day is $-0.08.
ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) percentage price change since previous trading day?
The percentage price change of ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) since the previous trading day is -0.978%.
What is the most recent average sentiment score for ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ)?
The most recent average sentiment score for ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ)?
The most recent sentiment for ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ) is .
SEC-8K** Filing Available For ACHIEVE LIFE SCIENCES INC (ACHV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.